BioArctic (Sweden) Today
| BIOA-B Stock | SEK 189.60 4.20 2.27% |
Performance5 of 100
| Odds Of DistressLess than 32
|
BioArctic is trading at 189.60 as of the 24th of November 2024, a 2.27% up since the beginning of the trading day. The stock's open price was 185.4. BioArctic has about a 32 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for BioArctic AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of November 2023 and ending today, the 24th of November 2024. Click here to learn more.
BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for neurodegenerative diseases in Sweden. BioArctic AB was founded in 1992 and is headquartered in Stockholm, Sweden. BioArctic is traded on Stockholm Stock Exchange in Sweden.. The company has 73.73 M outstanding shares. More on BioArctic AB
Moving against BioArctic Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioArctic Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioArctic's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioArctic or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
BioArctic AB (BIOA-B) is traded on Stockholm Exchange in Sweden and employs 61 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 26.34 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioArctic's market, we take the total number of its shares issued and multiply it by BioArctic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioArctic AB operates under Healthcare sector and is part of Biotechnology industry. The entity has 73.73 M outstanding shares.
BioArctic AB has accumulated about 848.4 M in cash with (140.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.84.
Check BioArctic Probability Of Bankruptcy
Ownership AllocationBioArctic holds a total of 73.73 Million outstanding shares. BioArctic AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioArctic Ownership Details
BioArctic AB Risk Profiles
Although BioArctic's alpha and beta are two of the key measurements used to evaluate BioArctic's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.76 | |||
| Semi Deviation | 2.91 | |||
| Standard Deviation | 4.83 | |||
| Variance | 23.35 |
BioArctic Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioArctic without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
BioArctic Corporate Management
Elected by the shareholders, the BioArctic's board of directors comprises two types of representatives: BioArctic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioArctic. The board's role is to monitor BioArctic's management team and ensure that shareholders' interests are well served. BioArctic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioArctic's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gunilla Andersson | Director HR | Profile | |
| Pr Gellerfors | Sr CoFounder | Profile | |
| Jan Mattsson | S Fin | Profile | |
| Christer Mller | VP Officer | Profile | |
| Gunilla Osswald | Chief Officer | Profile | |
| Pr Lannfelt | VP CoFounder | Profile | |
| Oskar Bosson | VP IR | Profile |
Other Information on Investing in BioArctic Stock
BioArctic financial ratios help investors to determine whether BioArctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioArctic with respect to the benefits of owning BioArctic security.